Delivery Order SPE2DR25D9367-SPE2DR26FKKH4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $12,364.81 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60 count). The award, issued on November 3, 2025, with an ultimate completion date of November 4, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating the vendor competed in an unrestricted procurement. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,364.81 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count). This firm fixed-price delivery order, issued on December 9, 2025, with an ultimate completion date of December 10, 2025, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. The award is...
- The Defense Logistics Agency issued a delivery order valued at $24,677 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 60 tablets of Jakafi 20 mg. The award, issued on December 11, 2025, with an ultimate completion date of December 12, 2025, utilized firm fixed-price pricing with no set-aside designation, indicating DMS Pharmaceutical Group competed successfully in an unrestricted procurement environment. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $24,493.16 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 15 mg tablets (60-count units). This firm fixed-price delivery order, awarded on December 2, 2025, with an ultimate completion date of December 3, 2025, was issued without set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal...
- The Defense Logistics Agency awarded a $12,364.81 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 60 tablets of Jakafi 10 mg. The award, issued on December 8, 2025, with an ultimate completion date of December 9, 2025, carries no set-aside designation and utilizes firm fixed-price pricing. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,396.58 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 5 mg tablets (60 count). This firm fixed-price delivery order, issued on November 24, 2025, with an ultimate completion date of November 25, 2025, was awarded without a set-aside designation, indicating the vendor competed in unrestricted federal procurement. DMS...
- The Defense Logistics Agency awarded a delivery order valued at $12,146.79 to DMS Pharmaceutical Group Inc. for the supply of Jakafi 5 mg tablets (60-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected as the awardee under a firm fixed-price contract type. The delivery order carries an ultimate completion date of July 11, 2025, with performance to be executed at the vendor's Park Ridge location. No...
- The Defense Logistics Agency awarded a $24,729.64 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for supply of Jakafi 10 mg tablets (60-count units). The delivery order, issued on November 28, 2025, with an ultimate completion date of December 1, 2025, carries no set-aside designation, indicating the award was made through open competition. This delivery order is issued under DMS...
- The Defense Logistics Agency awarded a $12,364.81 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for 60 tablets of Jakafi 10 mg. The contract was awarded on November 5, 2025, with an ultimate completion date of November 6, 2025, and carries no set-aside designation, indicating the awardee competed in unrestricted federal procurement. This delivery order is issued under DMS...
- The Defense Logistics Agency awarded a delivery order valued at $12,115.65 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). This firm fixed-price delivery order, issued on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a direct pharmaceutical supply transaction under DLA's established procurement framework. The contract carries no...
- SPE2DR25D9367Indefinite Delivery Contract
- SPE2DR25D9367-SPE2DR26FKKH4Delivery Order
The Defense Logistics Agency awarded a $12,246.58 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 60 tablets of Jakafi 15 mg. The award, issued on December 19, 2025, with an ultimate completion date of December 22, 2025, carries no set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to establish regional prime vendor contractors for the Department of Defense's pharmaceutical supply needs. DMS Pharmaceutical Group Inc. serves as a critical supplier within the federal pharmaceutical supply chain, distributing a comprehensive portfolio of branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals to military healthcare facilities. The company's parent IDC under PPV-G GEN V, valued at $499,999,999 and extending through December 31, 2036, authorizes the Defense Logistics Agency to issue firm fixed-price delivery orders for recurring medical supply needs across Department of Defense healthcare operations globally. This delivery order for Jakafi, an oncology treatment, exemplifies the contractor's role in supporting the specialized pharmaceutical requirements of the federal military medical system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.2k | 12/18/25 |